XTL BIOPHARMACEUTICALS LTD. Finance Costs
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Finance Costs of $1.56 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-22.
Discontinued › Operating Expenses
ifrs-full:FinanceCosts · last filed 2023-03-22
| Period end | Finance Costs 12 month | Finance Costs 12 month as first filed |
|---|---|---|
| 2022-12-31 | $1.56M 20-F · filed 2023-03-22 | |
| 2021-12-31 | $21.00K 20-F · filed 2023-03-22 | |
| 2020-12-31 | $2.19M 20-F · filed 2023-03-22 | $17.00K 20-F · filed 2021-03-15 |
| 2019-12-31 | $603.00K 20-F · filed 2022-03-30 | |
| 2018-12-31 | $35.00K 20-F · filed 2021-03-15 | |
| 2017-12-31 | $337.00K 20-F · filed 2020-03-12 | |
| 2016-12-31 | $7.00K 20-F · filed 2019-03-11 | |
| 2015-12-31 | $15.00K 20-F · filed 2018-03-15 |